Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis

• I. B. Chaudhry,
• M. O. Husain,
• A. B. Khoso,
• M. I. Husain,
• M. H. Buch,
• T. Kiran,
• B. Fu,
• P. Bassett,
• I. Qurashi,
• R. ur Rahman,
• S. Baig,
• A. Kazmi,
• F. Corsi-Zuelli,
• P. M. Haddad,
• B. Deakin,
• N. Husain

Affiliations

I. B. Chaudhry

Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre

M. O. Husain

Centre for Addiction and Mental Health

A. B. Khoso

Pakistan Institute of Living and Learning

M. I. Husain

Centre for Addiction and Mental Health

M. H. Buch

National Institute of Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust

T. Kiran

Pakistan Institute of Living and Learning

B. Fu

School of Data Science, Fundan University

P. Bassett

Stats Consultancy

I. Qurashi

Faculty of Biology, Medicine and Health, Division of Psychology and Mental Health, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre

R. ur Rahman

Dow University of Health Sciences

S. Baig

Baqai University

A. Kazmi

Karwan e Hayat

F. Corsi-Zuelli

Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo (FMRP—USP), São Paulo

P. M. Haddad

Hamad Medical Corporation

B. Deakin

Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre

N. Husain

Faculty of Biology, Medicine and Health, Division of Psychology and Mental Health, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre